검색어: ‘English Yakup’(으)로 검색된 결과입니다.
| 뉴스 |
-
[FDA WARNING] Risk of Suffocation
(편집자 주 - 지난 13년간 미국 FDA의 조사에 따르면 12명의 유아 (babies, 생후 6개월 미만) 들이 질식으로 사망한 이유는 잘못된 수면포지셔너 (sleep positioner - 잠잘때 유아의 목을 고정시키는 ...2010-09-30 06:00 -
Voluntary Nationwide Recall [VNR] by AMGEN
(편집자 주 - 글로벌 바이오 제약기업인 암젠 (Amgen)의 제품인 에포젠 (Epogen) 과 프로크리트 (Procrit)의 최근 미국 FDA의 리콜 조치와 관련, 암젠 (Amgen)사가 자발적인 전국 리콜을 전개한다는 내용입니다.)...2010-09-27 10:57
-
Government to Acknowledge Donations
September 20th, 2010. Seoul.The government will allow pharmaceutical firms to support overseas academic conferences here without restriction. In a press interview on September 16, the healt...2010-09-24 08:05
-
RECALL - Similac Infant Formulas
(편집자 주 - 글로벌 제약기업인 애보트 (Abbott) 미국법인은 9월 23일 "자사의 씨밀락 (Similac) 제품에 위장장애와 소화불량 등을 불러 일으킬 수 있는 벌레나 유충이 들어가 있다"며 "리콜에 돌입한다"고...2010-09-24 07:19
-
RESTRICT the Avandia Use
(편집자 주 - 미국FDA는 심장질환과 뇌졸중 부작용 우려가 제기된 영국 제약기업 글락소스미스클라인의 당뇨병 치료제 '아반디아 - Avandia'의 사용을 규제하는 조치를 발표한 내용입니다.). AUDIENCE...2010-09-24 06:31
-
Government, Multinational Pharma Giants in Octagon Bout
September 17th, 2010. Seoul.The Korean government and some of multinational pharma giants' local entities, including Pfizer Korea (한국 화이자), MSD Korea (한국 엠에스디), Abbott Korea (한국 ...2010-09-18 08:41
-
Actos and Bladder Cancer - Ongoing Safety Review
(편집자 주 - 한국릴리가 국내서 시판하는 당뇨병 치료제 '액토스 - Actos'의 심각한 부작용인 방광암에 대한 잠재적 가능성 상승을 미국 FDA가 발표한 내용입니다.) Actos (액토스, 성분명: pioglitazone): Ong...2010-09-18 06:34
-
Drug Price. To Be [REFORMED]
September 16th, 2010. Seoul. The government has a specific plan to gradually lower drug prices in Korea. The plan is to be implemented in October, and such decision draws a keen atten...2010-09-17 07:31
-
Will Kanarb Be [Rocky Balboa]?
September 12th. Seoul. Boryung Pharmaceuticals (보령제약), one of Korea's major pharma players, announced on September 9th that they have successfully received a marketing approval for their ...2010-09-14 00:34
-
This Time for Kanarb. Will Magic Happen?
Boryung Pharma (보령제약) said this week that the company has recently completed an extensive recruitment of 74 new employees to be deployed in the drug sales team for Kanarb (카나브), a novel prod...2010-09-11 09:14
-
Be Alert for DMF Revisions
September 9th, 2010. Seoul. The Korea Food and Drug Administration (KFDA) said that the agency plans to overhaul the current drug master file (DMF) program by Year 2015, in a bid to ensure a...2010-09-10 07:21
-
CJ, RaQualia Join Hands for Acid Pump Antagonists
September 8th, 2010. Seoul. CJ Cheil Jedang said on September 3rd that it has signed a licensing agreement with RaQualia Pharma Inc, a Japanese pharmaceutical venture, granting CJ an exclusi...2010-09-09 07:12
-
And the [Rx] Winner Is...
Daewoong Pharma has become the number-one prescription drug manufacturer in Korea in terms of EDI claim-based revenue in the first half of this year, according to data released by the Health Insura...2010-09-04 09:29
-
Nursing to Hit Insurers
September 3, 2010. Seoul. JoongAng Daily. Nursing costs for the elderly could soon be added to the health insurance coverage of non-life insurers by a proposed change in the National Health Insura...2010-09-03 09:09
-
The Solution May Be a Problem
[편집자 주 - 너무 어린 아이들이 강력한 향정신성 의약품에 쉽게 노출되어 있다는 기사입니다] At 18 months, Kyle Warren started taking a daily ...2010-09-03 08:54
|
서울시 서초구 서초대로 115 정다운빌딩 4층 TEL : 02-3270-0114 FAX : 02-3270-0189 E-mail : webmaster@yakup.com |
발행일 : 1954. 03. 29 등록일 : 2016. 05. 02 대표이사 : 함태원 발행 · 편집인 : 함태원 등록번호 : 서울,아04071 |
사업자등록번호 : 106-81-10940 통신사업자신고번호 : 제2022-서울서초-2586호 청소년보호책임자 : 이종운
Copyright © Yakup.com All rights reserved.
|
The Solution May Be a Problem
[IHT 특약] Experts Alarmed by Ranks of Young Children Taking Potent Drugs
- English Yakup 기자
- 입력 2010-09-03 08:54 수정
[편집자 주 - 너무 어린 아이들이 강력한 향정신성 의약품에 쉽게 노출되어 있다는 기사입니다]
At 18 months, Kyle Warren started taking a daily antipsychotic drug on the orders of a pediatrician to quell the boy's severe tempter tantrums.
Thus began a troubled toddler's journey from one doctor to another, from one diagnosis to another, involving even more drugs. Autism, bipolar disorder, hyperactivity, insomnia, oppositional defiant disorder. The boy's daily pill regimen multiplied: the antipsychotic Risperdal [리스페달], the antidepressant Prozac [프로작], two sleeping medicines and one for attention-deficit disorder. All by the time he was 3.
He was sedated, drooling and overweight from the side effects of the antipsychotic medicine. Although his mother, Brandy Warren, had been at her "wit's end" when she resorted to the drug treatment, she began to worry about Kyle's altered personality.
"All I had was a medicated little boy," Ms. Warren said. "I didn't have my son. It's like, you'd look into his eyes, and you would just see just blankness."
Today, Kyle, 6, is in his forth week of first grade, scoring high marks on his first tests. He is rambunctious and much thinner. Weaned off the drugs through a program affiliated with Tulane University in New Orleans [U.S.A.] that is aimed at helping low-income families whose children have mental health problems, Kyle now laughs easily and teases his family.
Ms. Warren and Kyle's new doctors point to his remarkable progress - and a more common diagnosis for children of attention-deficit hyperactivity disorder - as proof that he should have never been prescribed such powerful drugs in the first place.
Copyright © Yakup.com All rights reserved.
약업신문 의 모든 컨텐츠(기사)는 저작권법의 보호를 받습니다.
무단 전재·복사·배포 등을 금지합니다.
무단 전재·복사·배포 등을 금지합니다.